Access Statistics for Kurt Richard Brekke

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Bilateral monopolies and location choice 0 0 0 19 3 3 4 77
Can Competition Reduce Quality? 0 1 1 48 0 1 1 292
Can competition reduce quality? 0 0 0 38 0 0 0 80
Can competition reduce quality? 0 0 0 123 0 0 2 192
Can competition reduce quality? 0 0 1 109 0 0 1 304
Capital Taxation and Imperfect Competition: ACE vs. CBIT 0 0 0 12 0 0 1 55
Capital Taxation and Imperfect Competition: ACE vs. CBIT 0 0 0 17 0 0 2 98
Capital Taxation and Imperfect Competition: ACE vs. CBIT 0 0 0 16 0 1 3 65
Capital Taxation and Imperfect Competition: ACE vs. CBIT 0 0 0 8 0 0 2 46
Capital taxation and imperfect competition: ACE vs. CBIT 0 0 0 18 0 0 2 49
Competing with precision: incentives for developing predictive biomarker tests 0 0 0 14 0 0 0 14
Competing with precision: incentives for developing predictive biomarker tests 0 0 0 27 0 0 0 10
Competition and Physician Behaviour: Does the Competitive Environment Affect the Propensity to Issue Sickness Certificates? 0 0 0 11 0 0 1 42
Competition and Quality in Regulated Markets with Sluggish Demand 0 0 0 45 0 1 1 206
Competition and Quality in Regulated Markets: a Differential-Game Approach 0 0 0 82 0 0 2 383
Competition and Waiting Times in Hospital Markets 0 0 0 108 0 0 1 409
Competition and Waiting Times in Hospital Markets 0 0 0 143 2 2 3 578
Competition and Waiting Times in Hospital Markets 0 0 0 84 0 0 2 420
Competition and physician behaviour: Does the competitive environment the propensity to issue sickness certificates? 0 0 0 70 0 0 0 77
Competition and quality in regulated markets with sluggish demand 0 0 0 44 0 0 1 180
Competition and quality in regulated markets: a differential-game approach 0 0 0 149 2 2 3 489
Competition and quality in regulated markets: a differential-game approach 0 0 0 88 1 1 1 244
Competition matters: uniform vs. indication-based pricing of pharmaceuticals 0 5 15 15 2 20 24 24
Competition matters: uniform vs. indication-based pricing of pharmaceuticals 0 0 2 2 3 3 9 9
Competition, quality and integrated health care 0 0 2 67 0 1 4 76
Diffusion of Pharmaceuticals: Cross-Country Evidence of Anti-TNF drugs 0 0 0 28 0 0 0 96
Direct to Consumer Advertising in Pharmaceutical Markets 0 0 0 569 1 1 2 2,583
Direct-to-Consumer Advertising in Pharmaceutical Markets 0 0 0 16 0 0 7 98
Direct-to-Consumer Advertising in Pharmaceutical Markets 0 0 0 408 1 1 1 1,830
Do Treatment Decisions Depend on Physicians` Financial Incentives? 0 0 0 36 0 0 0 50
Do Treatment Decisions Depend on Physicians’ Financial Incentives? 0 0 1 10 0 1 3 66
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform 0 0 0 18 0 0 0 85
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform 0 0 0 22 0 0 2 14
Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform 0 0 0 72 0 0 2 152
Gatekeeping In Health Care 0 0 0 148 0 0 2 605
Gatekeeping in Health Care 0 0 0 252 0 2 2 1,811
Gatekeeping in health care 0 0 0 7 0 0 1 104
Horizontal Mergers and Product Quality 0 0 0 33 0 0 2 130
Horizontal Mergers and Product Quality 0 0 0 35 0 0 0 109
Horizontal Mergers and Product Quality 0 0 0 28 0 0 0 61
Horizontal Mergers and Product Quality- 0 0 1 60 0 0 3 141
Hospital Competition and Quality with Regulated Prices 0 0 0 306 1 1 2 1,109
Hospital Competition in the National Health Service: Evidence from a Patient Choice Reform 0 1 1 32 0 1 3 62
Hospital Competition in the National Health Service: Evidence from a Patient Choice Reform 0 0 0 70 1 1 2 141
Hospital Competition with Soft Budgets 0 0 0 48 1 1 1 193
Hospital Mergers with Regulated Prices 0 0 1 90 0 0 5 140
Hospital Mergers: A Spatial Competition Approach 0 0 0 37 0 1 2 127
Hospital Mergers: A Spatial Competition Approach 0 0 0 121 0 0 0 115
Hospital Reimbursement in an Oligopolistic Industry 0 0 0 0 0 0 2 1,042
Hospital competition and quality with regulated prices 0 0 0 149 1 2 3 386
Hospital competition with soft budgets 0 0 0 74 0 0 0 150
Hospital competition with soft budgets 0 0 0 46 0 0 0 123
Hospital competition with soft budgets 0 0 0 31 0 1 1 62
How does the type of remuneration affect physician behaviour? Fixed salary versus fee-for-service 0 2 2 72 0 2 2 142
Margins and Market Shares: Pharmacy Incentives for Generic Substitution 0 0 0 114 0 0 1 122
Margins and Market Shares: Pharmacy Incentives for Generic Substitution 0 0 2 36 2 3 6 207
Margins and Market Shares:Pharmacy Incentives for Generic Substitution 0 0 0 91 0 0 0 224
Patents: Incentives for R&D or Marketing? 0 0 0 9 0 0 2 51
Patient Mobility, Health Care Quality and Welfare 0 0 1 51 0 0 3 152
Patient Mobility, Health Care Quality and Welfare 1 1 1 54 1 1 3 121
Patient Mobility, Health Care Quality and Welfare 0 0 0 42 1 1 2 122
Patient Mobility, Health Care Quality and Welfare 0 0 0 45 0 0 1 163
Patient mobility and health care quality when regions and patients differ in income 1 1 1 14 1 1 2 67
Paying for pharmaceuticals: uniform pricing versus two-part tariffs 0 0 1 48 0 1 4 124
Pharmaceutical Patents: Incentives for R&D or Marketing? 0 0 0 275 0 0 3 1,091
Price Regulation and Parallel Imports of Pharmaceuticals 0 0 1 100 0 0 1 118
Price Regulation and Parallel Imports of Pharmaceuticals 0 0 0 13 1 1 3 117
Price Regulation and Parallel Imports of Pharmaceuticals 0 0 1 95 0 0 3 144
Price and quality in spatial competition 0 0 0 162 1 1 5 253
Price and quality in spatial competition 0 0 1 94 0 0 1 225
Private Versus Public Health Care in a National Health Service 0 0 1 1,282 0 0 8 6,000
Public coverage of dental care: universal or targeted? 0 0 0 0 1 2 4 4
Public coverage of dental care: universal or targeted? 0 0 7 7 2 2 6 6
Public versus Private Health Care in a National Health Service 0 0 0 1,228 1 1 2 6,640
Quality and location choices under price regulation 0 0 0 25 0 1 1 106
Quality and location choices under price regulation 0 0 0 21 0 0 1 108
Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms? 0 0 0 44 1 1 1 146
Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms? 0 0 1 108 0 0 2 202
Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms? 0 0 1 84 1 1 2 119
Reference Pricing of Pharmaceuticals 0 0 0 269 0 0 1 931
Reference Pricing of Pharmaceuticals 0 0 0 20 0 0 0 121
Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment 0 6 8 111 0 9 12 397
Reference pricing with endogenous generic entry 0 0 0 52 0 0 0 90
Reference pricing with endogenous generic entry 0 0 1 16 0 0 2 76
Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation? 0 0 2 24 0 0 5 139
Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation? 0 0 0 308 0 0 1 1,344
Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment 0 0 2 149 0 0 4 488
Socioeconomic Status and PhysiciansíTreatment Decisions 0 0 0 19 0 0 0 58
Socioeconomic Status and Physicians’ Treatment Decisions 0 0 0 10 0 0 1 70
Taking the competitor´s pill: when combination therapies enter pharmaceutical markets 0 0 0 0 0 0 1 4
Taking the competitor’s pill: when combination therapies enter pharmaceutical markets 0 0 0 12 0 0 2 23
The price of cost-effectiveness thresholds 1 1 2 27 1 1 3 16
The price of cost-effectiveness thresholds 0 0 0 24 1 1 4 15
Trade, renewable energy, and market power in power markets 0 0 2 15 0 1 11 34
Where are all the Physicans? Private vs. Public Health Care 0 0 0 1 0 0 1 3,324
Total Working Papers 3 18 63 9,274 34 79 235 39,908


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Bilateral monopolies and location choice 0 0 0 47 0 0 1 176
Can Competition Reduce Quality? 0 0 1 34 0 0 3 176
Capital taxation and imperfect competition: ACE vs. CBIT 0 0 0 15 0 2 2 97
Competing with precision: incentives for developing predictive biomarker tests 0 0 0 0 0 0 2 3
Competition and physician behaviour: Does the competitive environment affect the propensity to issue sickness certificates? 0 0 1 3 0 0 2 25
Competition and quality in health care markets: A differential-game approach 0 0 0 48 1 2 9 238
Competition and waiting times in hospital markets 0 0 2 133 0 0 2 503
Competition in Regulated Markets with Sluggish Beliefs about Quality 0 0 0 18 0 1 3 78
Competition or Coordination in Hospital Markets with Unionised Labour 0 0 0 31 0 0 1 186
Competition policy for health care provision in Norway 0 0 0 5 0 0 0 36
Competition, quality and integrated health care 0 0 1 4 1 1 9 13
Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs 0 0 0 1 0 0 2 66
Direct to consumer advertising in pharmaceutical markets 0 0 0 114 0 0 1 336
Do treatment decisions depend on physicians' financial incentives? 1 1 7 43 2 2 17 161
Gatekeeping in health care 0 0 0 170 0 0 4 738
Horizontal mergers and product quality 0 0 0 8 0 0 2 55
Horizontal mergers and product quality 0 0 0 2 0 0 2 32
Hospital Competition and Quality with Regulated Prices 0 0 0 58 0 1 7 196
Hospital Competition with Soft Budgets 0 0 0 9 0 0 3 63
Hospital Mergers with Regulated Prices 0 0 0 5 1 1 2 58
Hospital competition in a national health service: Evidence from a patient choice reform 0 1 2 6 1 4 10 31
How Does The Type of Remuneration Affect Physician Behavior? 0 0 2 30 2 7 11 88
Margins and market shares: Pharmacy incentives for generic substitution 0 0 0 55 0 2 7 323
Patient mobility and health care quality when regions and patients differ in income 0 0 0 17 0 0 0 75
Patient mobility, health care quality and welfare 0 1 1 22 0 1 4 99
Paying for pharmaceuticals: uniform pricing versus two-part tariffs 0 0 0 3 0 0 1 19
Pharmaceutical Patents: Incentives for Research and Development or Marketing? 0 0 0 0 0 0 0 2
Price and quality in spatial competition 0 0 1 57 0 0 6 244
Price regulation and parallel imports of pharmaceuticals 0 0 1 24 0 1 6 113
Public versus private health care in a national health service 0 0 0 168 0 0 0 687
Quality and Location Choices under Price Regulation 0 1 2 170 0 1 6 497
Quality competition with profit constraints 0 0 1 33 2 4 11 166
Reference pricing of pharmaceuticals 0 0 1 97 0 0 1 257
Reference pricing with endogenous generic entry 0 0 0 12 1 1 2 58
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment 0 0 0 75 0 2 2 336
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment 0 0 0 73 0 2 3 250
Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? 0 1 3 131 0 1 14 409
Socio‐economic status and physicians' treatment decisions 0 0 0 6 0 0 2 32
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets 0 0 0 4 0 2 8 19
Total Journal Articles 1 5 26 1,731 11 38 168 6,941


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Patient Choice, Mobility and Competition Among Health Care Providers 0 0 0 0 0 0 7 31
Total Chapters 0 0 0 0 0 0 7 31


Statistics updated 2025-07-04